MarginsXMarginsX
Home › Markets › CEROW

Cero Therapeutics Holdings, Inc. (CEROW)

CEROW is quoted over the counter, not listed on an exchange. Cero Therapeutics Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close
No daily closes stored yet
No new price since Oct 29, 2026: the price source has sent no bar for 12 sessions
1-year return
No daily closes stored yet
Market cap
Another share class (warrant); the SEC share count is the common shares, so no cap for this line
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to June 30, 2026 (10-Q)

Profile

FieldValue
TickerCEROW, quoted over the counter
SEC CIK0001870404
SEC industry codeBiological Products, (No Diagnostic Substances)
Business addressSouth San Francisco, CA
Incorporated inDE

Warning signs

Cash runway
1.9 months
$863K cash at June 30, 2026
Share count, 1 year
+294.8%
2025-11-19 to 2026-11-13
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year from the date these unaudited condensed consolidated financial statements are issued."
10-Q 2026-11-13
Cash and burn$863K cash; operating cash flow -$1.4M a quarter.Report 2026-06-30
Shares outstanding83,309,742 (2026-11-13); 21,102,671 a year earlier.Cover page 2026-11-13
Reverse splits, 3 years2; latest 1-for-20 on 2025-06-13Source 2025-06-13
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-02-03
Delisting25-NSE filed25-NSE 2026-07-13
AuditorSalberg & Company, P.A., Boca Raton, Florida, United States; changed auditors 1 time in 24 months8-K 4.01 2026-02-13
Late filings, 12 months2 NT noticesNT 10-K 2026-04-01
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$1.0M-$7.9M$863K$2.2MNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$5.9M$2.8M$857K$137KNeeds four quarters10-Q 2026-08-14
Q4 2025
2025-12-31
Not filed-$4.5MNot filed$1.7MNo debt tagsNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$4.9MNot filed$1.9MNo debt tagsNeeds four quarters10-Q 2025-11-19
Q2 2025
2025-06-30
Not filed-$5.4MNot filed$3.2MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$5.1MNot filed$5.1MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q3 2024
2024-09-30
Not filed-$4.2MNot filed$3.4MNo debt tagsNeeds four quarters10-Q 2025-11-19
Q2 2024
2024-06-30
Not filed-$2.4MNot filed$3.6MNo debt tagsNeeds four quarters10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-08-14
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-10-07
Latest proxyDEFA14A2025-12-02

Source: SEC EDGAR submissions feed, 446 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier